Results 101 to 110 of about 41,447 (182)

Asciminib for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia

Blood Advances
Mathilde Chanut, Aurélie Cabannes-Hamy, Marie Balsat, Nassim Sahki, Emmanuel Raffoux, Yosr Hicheri, Bruno Lioure, Lucie Laemmel, Thibaut Leguay, Victoria Cacheux, Maria Pilar Gallego-Hernanz, Andrea Pieragostini, Gabrielle Roth-Guepin, Ludovic Gabellier, Nathalie Denizon, Lise Willems, Quentin Cabrera, Sylvain Chantepie, Valérie Coiteux, Claudie Capdupuy, Martin Carré, Antoine Machet, Juliette Lambert, Sandrine Roux, Franck-Emmanuel Nicolini, Nicolas Boissel, Emmanuelle Clappier, Rathana Kim, Philippe Rousselot   +28 more
doaj   +1 more source

Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]

Nucleic Acids Res
Sharma S, Thomas E, Dahal S, Das S, Kothari S, Roy U, Kumari N, Gopalakrishnan V, Raghavan SC.   +8 more
europepmc   +1 more source

Pseudohypoxemia From Leukocyte Larceny in a Patient With Chronic Myelogenous Leukemia. [PDF]

Cureus, 2022
Mirzai S, Andreae M, Puttarajappa C.
europepmc   +1 more source

Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia. [PDF]

Cureus
Dogra R, Dogra V, Shelke AR.
europepmc   +1 more source

Pericardial Effusion Secondary to Nilotinib in an Elderly Patient With Chronic Myelogenous Leukemia. [PDF]

Cureus, 2022
Arora G, Adinugraha P, Aijaz A, Vargas Pelaez A, Rachko M.   +4 more
europepmc   +1 more source

Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]

Ann Med Surg (Lond)
Zhu F, Wang H, Qiu L.
europepmc   +1 more source

Brassinin Induces Apoptosis, Autophagy, and Paraptosis via MAPK Signaling Pathway Activation in Chronic Myelogenous Leukemia Cells. [PDF]

Biology (Basel), 2023
Yang MH, Ha IJ, Lee SG, Lee J, Um JY, Sethi G, Ahn KS.   +6 more
europepmc   +1 more source

Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting. [PDF]

Cancer Med
Awlachew WY, Tasamma AT, Mengistie FA, Alemineh ZT, Tefera ST.   +4 more
europepmc   +1 more source

Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications.

Cancers (Basel), 2023
Ouyang D, Ye N, Yang K, Wang Y, Hu L, Chao S, Toner M, Li Y.   +7 more
europepmc   +1 more source

RETRACTED: Ouyang et al. Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications. <i>Cancers</i> 2023, <i>15</i>, 5696. [PDF]

Cancers (Basel)
Ouyang D, Ye N, Yang K, Wang Y, Hu L, Chao S, Li Y.   +6 more
europepmc   +1 more source